A first aid kit made by Johnson & Johnson for sale on a store in Westminster, Colorado April 14, 2009. REUTERS/Rick Wilking
(Copyright Reuters, 2015)
NEW YORK – Johnson & Johnson is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals.
Actelion Pharmaceuticals Ltd. makes high blood pressure medicines for the treatment of the arteries in the lungs and around the heart. Johnson & Johnson of New Brunkswick, New Jersey, develops medicines and produces medical equipment and other consumer products.
More about this…
Drugmakers improving access for poor, GSK ranked top
Drugmakers turn cheap generic drugs in expensive pills
35 US states sue British drugmaker over the marketing of opioids
Shares of Johnson & Johnson rose 93 cents to $114 in the afternoon trade Friday.